Cryptococcus neoformans-Cryptococcus gattii species complex: An international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for amphotericin B and flucytosine

A. Espinel-Ingroff, A. Chowdhary, M. Cuenca-Estrella, A. Fothergill, J. Fuller, F. Hagen, N. Govender, J. Guarro, E. Johnson, C. Lass-Flörl, S. R. Lockhart, M. A. Martins, J. F. Meis, M. S.C. Melhem, L. Ostrosky-Zeichner, T. Pelaez, M. A. Pfaller, W. A. Schell, L. Trilles, S. KiddJ. Turnidges

Research output: Contribution to journalArticlepeer-review

85 Scopus citations

Fingerprint Dive into the research topics of 'Cryptococcus neoformans-Cryptococcus gattii species complex: An international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for amphotericin B and flucytosine'. Together they form a unique fingerprint.

Medicine & Life Sciences